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ORIGINAL ARTICLE BACTERIOLOGYFamilial Q fever clustering with variable manifestations imitating
infectious and autoimmune diseaseA. Abu Rmeileh1, T. Khoury1, K. Meir2, A. Drori1, M. Shalit1, S. Benenson3 and H. Elinav3
1) Department of Internal Medicine, 2) Department of Pathology and 3) Department of Clinical Microbiology and Infectious Diseases, Hadassah-Hebrew
University Medical Center, Jerusalem, IsraelAbstractQ fever, caused by Coxiella burnetii, can present as an outbreak of acute disease ranging from asymptomatic disease, pneumonia, hepatitis or
fever of unknown origin, which can progress to a chronic disease, most frequently endocarditis. The occurrence of Q fever within families is
rarely described, and in most cases presents with uniform acute disease manifestations. Here we present a familial cluster of Q fever
presenting as highly variable synchronous manifestations in four of ﬁve family members, including prolonged fever of unknown origin,
asymptomatic carrier state, hepatitis, and chronic endocarditis developing in the absence of previous symptoms. This case series
highlights the possibility of Q fever developing in cohabitated individuals with highly variable symptoms masking the common disease
etiology. Screening of all exposed individuals, even those not clinically suspected to be infected, may enable to better identify, treat and
prevent progression to chronic disease.
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The ﬁrst two authors contributed equally to this manuscript.Case presentationA 55-year-old previously healthy male patient was hospitalized
due to 2 weeks of daily high-grade fever and elevated liver
enzymes. Two weeks before his admission the patient under-
went dental transplantation and was treated with amoxicillin for
3 days. Since then and until his referral, the patient suffered
daily spiking fever of up to 39°C and weight loss of 6 kg. The
patient did not suffer of headache, odynophagia, dyspnea,
dysuria, diarrhea, arthritis or rash. The patient’s family history
revealed two additional cases of prolonged fever, with one
family member diagnosed with infectious mononucleosis andClinical Microbiology and Infection © 2015 European Society of Cthe other with fever and hepatitis without identiﬁed etiology,
which spontaneously resolved.
Vital signs were remarkable for temperature of 38.3°C and
tachycardia of 135 beats/min. No other pathologies were noted
on physical examination. Laboratory workup revealed elevated
sedimentation rate of 60 mm3/h, mild leukocytosis of 11*103 μL
with differential count of 80% neutrophils, and normocytic
anaemia with haemoglobin levels of 10 g/dL. Mildly elevated
liver enzymes were noted with aspartate aminotransferase of
104 U/L (normal range 0 to 35 U/L), alanine aminotransferase
of 138 U/L (normal range 0 to 40 U/L), and CRP of 22.8 mg/dL
(<0.5 mg/dL). Ferritin levels were 1600 ng/mL (normal range 10
to 300 ng/mL). Multiple blood and urine cultures were
repeatedly sterile.
Serological tests for HIV, viral hepatitis, and Brucella were
negative; Cytomegalovirus, Epstein Barr Virus and Herpes Simplex
type 1 and 2 serology indicated past infection; whereas Parvo-
virus antibodies immunoglobulin (Ig) G and IgM were both
positive in high titer, compatible with recent infection.Clin Microbiol Infect 2015; 21: 459–463
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positive antinuclear antibodies with FITC intensity (ﬂuorescein
isothiocyanate) at the level of 2 on a scale of 0 to 4 (Kallestad,
BioRAD), negative cytoplasmic anti-neutrophil cytoplasmic an-
tibodies and perinuclear anti-neutrophil cytoplasmic antibodies,
positive anti-smooth muscle antibody with FITC intensity at the
level of 2 on a scale of 0 to 4 (Kallestad, BioRAD), elevated
anticardiolipin immunoglobulins of both the IgM and IgG frac-
tions, and anti-beta 2 glycoprotein immunoglobulin M. Free
serum antibody light chains analysis indicated increased levels of
free kappa chains of 21.5 mg/L (3.3 to 19.4 mg/L) and polyclonal
gammopathy documented in plasma electrophoresis. These
ﬁndings raised the suspicion for malignancy, thus further inves-
tigation included positron emission tomography–computed to-
mography that showed pathological focal uptake in the left knee,
pleural effusion and a focus between the great thoracic vessels.
The later ﬁndings did not correlate with ﬁndings in transthoracic
echocardiogram and transesophageal echocardiogram, which
only showed mild to moderate mitral valve regurgitation
without vegetation or abscess. Bone marrow biopsy revealed a
ﬁbrin ring and epithelioid granulomas, highly compatible with Q
fever. A liver biopsy supported the diagnosis demonstrating
eosinophilic, plasma cells and neutrophilic inﬁltrates, micro-
vesicular and macrovesicular fatty changes.
Enzyme immunoassay of Q fever (Immunodot Q Fever,
GenBio, CA, USA) was compatible with acute Q fever, as well
as serology of Q fever performed by the national reference
laboratory using an indirect ﬂuorescence assay. Phase 2 anti-
bodies IgM level was marginal and IgG level was positive at a
titer of 1:1600. Phase 1 IgM level was borderline positive and
IgG was negative (cutoff for IgG  1:100) (case 1, Table 1,
Fig. 1).
Treatment with doxycycline for 2 weeks did not result in any
clinical improvement, thus hydroxychloroquine was added,
leading to disappearance of fever within 2 days of treatment.
Two months later, follow-up blood evaluation indicated normal
erythrocyte sedimentation rate, disappearance of autoanti-
bodies and normalization of immunoglobulin levels.
The patient’s family was screened for Q fever. Enzyme
immunoassay of Q fever (Immunodot Q Fever, GenBio) test of
the daughter with fever and hepatitis was negative whenTABLE 1. Clinical presentations and serology of Q fever of all case
Case # Age Sex Presentation Serology Phase 2 Serology Pha
1 55 M FUO IgG 1:3200 IgG 1:400
2 24 F Hepatitis IgG 1:400 IgG: Borderline
3 14 F FUO IgG 1:3200 IgG 1:1600
4 28 M Asymptomatic IgG 1:400 IgG negative
5 48 F Not infected IgG negative IgG negative
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectperformed during her acute disease. After the diagnosis of the
index case, serology for Q fever was performed using indirect
ﬂuorescence assay, and was this time consistent with acute Q
fever. Phase 2 IgM was positive, and IgG titer was 1:400. Phase 1
IgM was positive, but IgG was negative (case 2, Table 1, Fig. 1).
This patient was not treated with doxycycline since she was
asymptomatic at the time of Q fever diagnosis, with her liver
enzymes already within the normal range and no evidence of
valvulopathy by transthoracic echocardiography. Follow-up
serology showed persistence of the phase 1 IgG at the same
titer as at diagnosis, as previously described by Dupont et al [1].
The serology of the daughter previously misdiagnosed with
infectious mononucleosis (due to the presence of anti-Epstein-
Barr virus nuclear antigen antibodies), was consistent with
chronic Q fever as phase 2 IgM was positive, IgG was 1:3200
and phase 1 IgM was positive, IgG was 1:1600. (case 3, Table 1,
Fig. 1). Consequently this patient, who did not have a predis-
posing valvular defect, underwent a transesophageal echocar-
diogram and an obvious small vegetation of 3 mm in size (typical
of Q fever) was observed on a mildly thickened anterior cusp of
the mitral valve. Because the diagnosis of Q fever endocarditis
was deﬁnite according to modiﬁed Duke criteria [2] and
possible according to the suggested revised criteria by Raoult
[3], treatment with doxycycline and hydroxychloroquine was
initiated and resulted in a rapid decrease of the titers of phase 1
IgG to borderline in 3 months.
A fourth family member, who was asymptomatic, was diag-
nosed with acute Q fever when IgM phase II antibodies were
positive, IgG titer was 1:400, and phase I antibodies were
negative. Although one cannot exclude that these serological
ﬁndings are due to persistence of antibodies resulting from
unrelated past infection (case 4, Table 1, Fig. 1). The ﬁfth family
member was found to be uninfected with Q fever (case 5,
Table 1, Fig. 1).DiscussionThe familial clustering presented in this case series highlights
three unusual and often neglected aspects of Q fever—a wide
range of presentations within close family contacts, thes described in the article
se 1 Echocardiography Treatment
Mild to moderate mitral
regurgitation
Doxycycline + hydroxychloroquine 18 mon
Normal None
3 mm vegetation, mildly
thickened mitral valve
Doxycycline + hydroxychloroquine-still active
Normal None
NA NA
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FIG. 1. Family tree describing the
clinical presentations of all cases.
Circle, female; rectangle, male; cross,
previously deceased individual.
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mune disease and the failure of doxycycline in the treatment of
acute Q fever.
Coxiella burnetii is an intracellular bacteria that causes Q fever
in humans, mainly through inhalation of aerosolized bacteria
from feces, urine or products of conception of infected animals
[4,5]. Although it is most commonly described in relation with
exposure to domestic mammals, the reservoir includes every
domestic or wild mammal, arthropods and birds [6,7]. Hori-
zontal transmission between humans is rarely reported, and
uniformly presented with similar clinical presentations of
infected family members. Mann et al reported Q fever within
ﬁve members of the same family. The infected family members
were living physically apart from each other, and presented
within weeks apart. They all presented with pneumonias and
were suspected to be infected by a shepherd family member
[8]. Sexual transmission of Q fever was identiﬁed serologically
in 9 Spanish shepherds and their wives, without any other
family members infected [9]. Q fever infection can present with
a wide range of symptoms from being totally asymptomatic to
severe systemic infection, pneumonia and hepatitis [10,11]. It
can also present as a chronic disease manifesting mainly as
endocarditis, vascular infection, hepatitis, pericarditis and
osteomyelitis in speciﬁc populations at risk. The main risk fac-
tors for the development of chronic infection are vascularClinical Microbiology and Infection © 2015 European Society of Clinical Microbiologygrafts, artiﬁcial valves, valvulopathies [12], immunosuppression,
and pregnancy [13–15]. Only few reports of Q fever clustering
in family members were reported in the English literature,
transmitted secondary to exposure to common infected cats,
dogs and/or pigeons [7,8,16,17]. In all of these cases, the familial
clinical presentation was uniform. In contrast to all previous
cases, our cluster represents a previously unreported scenario
in which close family members had different Q fever clinical
manifestations, although very likely infected from a common
source—a kitten that was brought home by patient 2. Because
the mother cat was killed by a car accident away from the family
house, none of the other family members was exposed to it.
The fact that some of the infected family members were not
genetically associated with each other (e.g. one family member
was adopted in her childhood (case 2, Fig. 1), and the other two
siblings had different mothers (case 3 and case 4, Fig. 1) may
indicate the importance of genetic background in inﬂuencing
and even driving different Q fever clinical presentations and
merits further studies.
Due to the clinical presentation variability, initial misdiag-
nosis of two of the family members and different family names,
the familial connection was initially overlooked. Only epidemi-
ological investigation tied the strings and identiﬁed the probable
source of infection, a young kitten that was adopted by the
family. Otherwise the diagnosis of three members of this familyand Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 459–463
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disease despite the lack of any risk factor. Although it is rec-
ommended that when an outbreak is identiﬁed, high-risk groups
for chronic disease should be screened [18], we believe that
when Q fever is diagnosed, epidemiological investigation is
essential and all contacts should be actively allocated and
evaluated due to the potential hazardous consequences of
infection with Coxiella burnetii.
As in the index case presented earlier, nonspeciﬁc occur-
rence of false-positive antibodies in patients may lead to a
wrong diagnosis because both the clinical presentation and the
serological appearance may mimic multiple viral and autoim-
mune diseases [19]. In a large retrospective analysis of acute Q
fever cases in Israel, positive serology for other infectious dis-
eases was noticed, including elevated IgM levels for Epstein-Barr
Virus, Cytomegalovirus, Mycoplasma pneumonia, Parvovirus,
Bordetella pertussis, Rickettsia conorii and Rickettsia typhi, noted
in 13.8%, 8.3%, 12.12%, 22.2%, 25%, 13% and 21.7% of cases,
respectively [20]. False-positive HIV serology also was re-
ported by de la Calle et al [21], Morera Montes et al [22] from
Spain, and Yale et al from the United States [23].
Because the immunological reaction in Q fever is robust, the
development of autoantibodies in Q fever, as presented in this
series, is frequently noted. Antimitochondrial antibodies and
anti–smooth muscle antibodies have been described in Q fever,
with a prevalence of 33% [20,24]. These autoantibodies were
detected in the acute phase (27%) as well as in the chronic
phase (38%). The presence of antiphospholipid Ab and anti-
cardiolipin (aCL) in Q fever is a well-recognized phenomenon
with estimated prevalence of 81% and 76%, respectively [25].
Recently it was shown by Million et al that high levels of aCL
correlate to evolution of acute Q fever to endocarditis [26]. It
was suggested that this can serve as a surrogate marker for
valvulopathies and is predictive of progression to endocarditis
in the absence of preventive treatment. In cases without
valvular pathology, serum level of aCL > 90 GPL units is
considered an indication to perform transesophageal echocar-
diography [26].
The index case presented with an unusual severely acute Q
fever that did not respond to 2 weeks of treatment with
doxycycline while the expected time to response is 1.7 to 4
days [10,27]. Slow regression of symptoms in patients with Q
fever is reported anecdotally. In a case series of patients
suffering from acute Q fever hepatitis accompanied by auto-
antibodies (smooth muscle antibodies and cold agglutinins), the
addition of steroids obtained apyrexia [10,24]. Munckhof et al
described the recovery of a critically ill patient when rifampin
was added after 5 days of intravenous doxycycline [28]. In our
case the treatment failure might be attributed to the dissemi-
nated disease (hepatic and bone marrow involvement). The factClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectthat Coxiella burnetii is an acidophilic bacterium whose meta-
bolism is enhanced at an acidic pH might explain the synergistic
effect of hydroxychloroquine that increase the pH in the
lysosome [29,30].
In summary, Q fever is a zoonotic disease with different
clinical manifestations that can masquerade as autoimmune
disease due to uncontrolled autoantibody production. The
clinical manifestation of infected individuals is probably related
not only to virulence factors in speciﬁc clones but also to genetic
factors. Because of the potential evolution to chronic disease,
we suggest that in case of an outbreak, every exposed individual
should be serologically screened and evaluated accordingly.Transparency declarationThere is no conﬂict of interest to declare.
References[1] Dupont HT, Thirion X, Raoult D. Q fever serology: cutoff determi-
nation for microimmunoﬂuorescence. Clin Diagn Lab Immunol 1994;1:
189–96.
[2] Li JS, Sexton DJ, Mick N, Nettles R, Fowler Jr VG, Ryan T, et al.
Proposed modiﬁcations to the Duke criteria for the diagnosis of
infective endocarditis. Clin Infect Dis 2000;30:633–8.
[3] Raoult D. Chronic Q fever: expert opinion versus literature analysis
and consensus. J Infect 2012;65:102–8.
[4] Morita C, Katsuyama J, Yanase T, Ueno H, Muramatsu Y, Hohdatsu T,
et al. Seroepidemiological survey of Coxiella burnetii in domestic cats in
Japan. Microbiol Immunol 1994;38:1001–3.
[5] Fishbein DB, Raoult D. A cluster of Coxiella burnetii infections associ-
ated with exposure to vaccinated goats and their unpasteurized dairy
products. Am J Trop Med Hyg 1992;47:35–40.
[6] Georgiev M, Afonso A, Neubauer H, Needham H, Thiery R,
Rodolakis A, et al. Q fever in humans and farm animals in four Euro-
pean countries, 1982 to 2010. Euro Surveill 2013;18(8).
[7] Stein A, Raoult D. Pigeon pneumonia in Provence: a bird-borne Q
fever outbreak. Clin Infect Dis 1999;29:617–20.
[8] Mann JS, Douglas JG, Inglis JM, Leitch AG. Q fever: person to person
transmission within a family. Thorax 1986;41:974–5.
[9] Kruszewska D, Lembowicz K, Tylewska-Wierzbanowska S. Possible
sexual transmission of Q fever among humans. Clin Infect Dis 1996;22:
1087–8.
[10] Maurin M, Raoult D. Q fever. Clin Microbiol Rev 1999;12:518–53.
[11] Hogema BM, Slot E, Molier M, Schneeberger PM, Hermans MH, van
Hannen EJ, et al. Coxiella burnetii infection among blood donors during
the 2009 Q-fever outbreak in The Netherlands. Transfusion 2012;52:
144–50.
[12] Fenollar F, Fournier PE, Carrieri MP, Habib G, Messana T, Raoult D.
Risk factors and prevention of Q fever endocarditis. Clin Infect Dis
2001;33:312–6.
[13] Parker NR, Barralet JH, Bell AM. Q fever. Lancet 2006;367:679–88.
[14] Raoult D, Marrie T, Mege J. Natural history and pathophysiology of Q
fever. Lancet Infect Dis 2005;5:219–26.
[15] Raoult D, Tissot-Dupont H, Foucault C, Gouvernet J, Fournier PE,
Bernit E, et al. Q fever 1985-1998. Clinical and epidemiologic features
of 1,383 infections. Medicine 2000;79:109–23.ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 459–463
CMI Abu Rmeileh et al. Q fever: one family, various manifestations 463[16] Pinsky RL, Fishbein DB, Greene CR, Gensheimer KF. An outbreak of
cat- associated Q fever in the United States. J Infect Dis 1991;164:
202–4.
[17] Buhariwalla F, Cann B, Marrie TJ. A dog-related outbreak of Q fever.
Clin Infect Dis 1996;23:753–5.
[18] Kampschreur LM, Delsing CE, Groenwold RH, Wegdam-Blans MC,
Bleeker-Rovers CP, de Jager-Leclercq MG, et al. Chronic Q fever in
The Netherlands 5 years after the start of the Q fever epidemic: re-
sults from the Dutch chronic Q fever database. J Clin Microbiol
2014;52:1637–43.
[19] Fournier PE, Marrie TJ. Raoult D.Diagnosis of Q fever. J Clin Microbiol
1998;36:1823–34.
[20] Vardi M, Petersil N, Keysary A, Rzotkiewicz S, Laor A, Bitterman H.
Immunological arousal during acute Q fever infection. Eur J Clin
Microbiol Infect Dis 2011;30:1527–30.
[21] de la Calle N, Yebra M, Portero F, López E. False positivity of anti-
bodies against human immunodeﬁciency virus in a case of Q fever. Rev
Clin Esp 1998;198:401.
[22] Morera Montes J, Arribas Blanco JM, Maisonave González A, Rollán
Hernández MA. False positive result for antibodies against human
immunodeﬁciency virus in Q fever. Med Clin (Barc) 1988;91:39.
[23] Yale SH, de Groen PC, Tooson JD, Kurtin PJ. Unusual aspects of acute
Q f ever-associated hepatitis. Mayo Clin Proc 1994;69:769–73.Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology[24] Levy P, Raoult D, Razongles JJ. Q-fever and autoimmunity. Eur J Epi-
demiol 1989;5:447–53.
[25] Ordi-Ros J, Selva-O’Callaghan A, Monegal-Ferran F, Monasterio-
Aspiri Y, Juste-Sanchez C, Vilardell-Tarres M, et al. Prevalence, sig-
niﬁcance, and speciﬁcity of antibodies to phospholipids in Q fever. Clin
Infect Dis 1994;18:213–8.
[26] Million M, Walter G, Bardin N, Camoin L, Giorgi R, Bongrand P, et al.
Immunoglobulin G anticardiolipin antibodies and progression to Q
fever endocarditis. Clin Infect Dis 2013;57:57–64.
[27] Spelman DW. Q fever: a study of 111 consecutive cases. Med J Aust
1982;1:547–53.
[28] Munckhof WJ, Runnegar N, Gray TJ, Taylor C, Palmer C, Holley A.
Two rare severe and fulminant presentations of Q fever in patients
with minimal risk factors for this disease. Internal Med J 2007;37:
775–8.
[29] Akporiaye ET, Rowatt JD, Aragon AA, Baca OG. Lysosomal response
of a murine macrophage-like cell line persistently infected with Coxiella
burnetii. Infect Immun 1983;40:1155–62.
[30] Raoult D, Drancourt M, Vestris G. Bactericidal effect of doxycycline
associated with lysosomotropic agents on Coxiella burnetii in P388D1
cells. Antimicrob Agents Chemother 1990;34:1512–4.and Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 459–463
